Our mission is to minimise the impact of infectious diseases and antimicrobial resistance on human health in Liverpool, the UK and globally. We’re committed to excellence in our research activity, with diversity, integrity and equality at the essence of everything we do.
AMR is a major threat to humanity. The consequences of failure to address AMR are that modern medicine will collapse; leukaemia will not be survivable, transplantation is unfeasible, surgery will become incredibly dangerous; and otherwise, trivial infections will become potentially life-threatening.
Our partnership consists of Liverpool University Hospitals NHS Foundation Trust, Liverpool School of Tropical Medicine, Alder Hey Children’s Hospital, The Clatterbridge Cancer Centre, Liverpool Heart and Chest Hospital, Mersey Care NHS Foundation Trust, Liverpool Women’s Hospital, The Walton Centre, with these represented by Liverpool Health Partners. Other academic and industrial collaborations bring additional expertise and critical mass to the Centre and increase capacity across Liverpool City Region (LCR).
Liverpool has a long, illustrious history in research into infectious diseases, clinical pharmacology and global health. We channel our world-leading resources in these areas into protecting public health. Through multidisciplinary working, tying together knowledge from local and global communities, we produce outcomes with measurable public health, clinical and commercial benefits.